BPC-157 vs TB-500
Two peptides most studied in preclinical tissue-repair research, often compared and sometimes studied together.
- BPC-157 derives from a gastric-juice sequence; TB-500 relates to the actin-binding protein thymosin beta-4.
- Both are studied for angiogenesis and tissue repair in animal models, via different proposed pathways.
- Neither is approved for human use; both are sold for laboratory research only.
BPC-157
A synthetic pentadecapeptide based on a partial sequence identified in human gastric juice. It is one of the most-studied peptides in preclinical tissue-repair research.
read more →
TB-500
A synthetic peptide related to the actin-binding protein thymosin beta-4, studied alongside BPC-157 in preclinical recovery research.
read more →
// for research use only. not for human consumption. nothing here is medical advice.